Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Mar;13(3):456–457. doi: 10.1111/j.1365-2125.1982.tb01405.x

Effect of oral 16,16-dimethyl-prostaglandin E2 on basal acid output in man.

H G Dammann, P Müller, B Simon
PMCID: PMC1402121  PMID: 7059450

Full text

PDF
456

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gibiński K., Rybicka J., Mikoś E., Nowak A. Double-blind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues. Gut. 1977 Aug;18(8):636–639. doi: 10.1136/gut.18.8.636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ippoliti A. F., Isenberg J. I., Hagie L. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients. Gastroenterology. 1981 Jan;80(1):55–59. [PubMed] [Google Scholar]
  3. Ippoliti A. F., Isenberg J. I., Maxwell V., Walsh J. H. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology. 1976 Apr;70(4):488–491. [PubMed] [Google Scholar]
  4. Kollberg B., Johansson C. The inhibitory effect of 15(R)15 methyl prostaglandin E2 and the interaction with atropine on stimulated gastric acid secretion in man. Scand J Gastroenterol. 1979;14(3):337–342. doi: 10.3109/00365527909179893. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES